Among chronic DILI, persistent DILI is defined by the International Expert Committee in 2011 as abnormalities in liver markers persisting for more than 3 months in the hepatocellular injury type and more than 6 months in the cholestatic injury type after discontinuation of the causative drug, whereas chronic DILI is defined as abnormalities in liver markers persisting for more than 12 months regardless of the phenotype of DILI. 24 Chronic DILI may cause drug-induced AIH (DI-AIH), nonalcoholic steatohepatitis-like conditions, vanishing bile duct syndrome, nodular regenerative hyperplasia, peliosis hepatis, and liver cirrhosis (Table 1)
Melatonin induces an increase in the expression of p53 and p21/WAF, which act as negative regulators by inhibiting cyclin-dependent kinases and preventing the phosphorylation of the Rb (retinoblastoma protein), which is part of the last checkpoint of the G1 phase
This differential expression of -glutamyl transpeptidase is conferred by different promoters in the 5'-untranslated regions of mRNAs generated in different tissues and at different stages of development (Ikeda and Taniguchi, 2005)
Organ-Specific Screening for Protein Damage Using Magnetic Bead Bioreactors and LC-MS/MS